QT Imaging Holdings, Inc. (Nasdaq: QTIH) is a medical technology company that became publicly traded through a special purpose acquisition company business combination, completing its de-SPAC transaction in 2023. The company develops quantum ultrasound breast imaging systems, offering three-dimensional, radiation-free imaging as a non-ionizing alternative to conventional mammography. QTIH operates in the medical device and diagnostic imaging sector, with its technology targeting early breast cancer detection. The company filed an 8-K current report with the Securities and Exchange Commission on August 31, 2026. Investors and analysts seeking full filing history, sponsor details, and deal metrics for QTIH can access comprehensive data by signing up at SpacDesk.